Genetic Variability among Complete Human Respiratory Syncytial Virus Subgroup A Genomes: Bridging Molecular Evolutionary Dynamics and Epidemiology

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Tan, Lydia ^a   Lemey, Philippe ^b   Houspie, Lieselot ^b   Viveen, Marco C ^a   Jansen, Nicolaas J G ^c   van Loon, Anton M ^a   Wiertz, Emmanuel ^a   van Bleek, Grada M ^c   Martin, Darren P ^d   Coenjaerts, Frank E ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; ARTICLE; DIVERSIFYING SELECTION; EPIDEMIC; EPIDEMIOLOGY; G GENE; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; GENETIC VARIABILITY; GENOME IMPRINTING; MOLECULAR EVOLUTION; NONHUMAN; PHYLOGENY; POPULATION SIZE; PROTEIN DOMAIN; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS GENE; VIRUS GENOME; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; BAYES THEOREM; BELGIUM; CHILD, PRESCHOOL; DNA PRIMERS; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOME, VIRAL; GENOMICS; HUMANS; INFANT; INFANT, NEWBORN; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION RATE; NETHERLANDS; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SUBGROUP A;

EID: 84870920810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051439     Document Type: Article

References (72)

1. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, et al. (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545-1555.
2. Glezen WP, Taber LH, Frank AL, Kasel JA, (1986) Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 140: 543-546.
3. Henrickson KJ, Hoover S, Kehl KS, Hua W, (2004) National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J 23: S11-18.
4. Falsey AR, Walsh EE, (2000) Respiratory syncytial virus infection in adults. Clin Microbiol Rev 13: 371-384.
5. Englund JA, Anderson LJ, Rhame FS, (1991) Nosocomial transmission of respiratory syncytial virus in immunocompromised adults. J Clin Microbiol 29: 115-119.
6. Fleming DM, Cross KW, (1993) Respiratory syncytial virus or influenza? Lancet 342: 1507-1510.
7. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE, (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352: 1749-1759.
8. White LJ, Mandl JN, Gomes MG, Bodley-Tickell AT, Cane PA, et al. (2007) Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models. Math Biosci 209: 222-239.
9. Anderson LJ, Hendry RM, Pierik LT, Tsou C, McIntosh K, (1991) Multicenter study of strains of respiratory syncytial virus. J Infect Dis 163: 687-692.
10. Cane PA, Matthews DA, Pringle CR, (1994) Analysis of respiratory syncytial virus strain variation in successive epidemics in one city. J Clin Microbiol 32: 1-4.
11. Peret TC, Hall CB, Hammond GW, Piedra PA, Storch GA, et al. (2000) Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis 181: 1891-1896.
12. Mufson MA, Orvell C, Rafnar B, Norrby E, (1985) Two distinct subtypes of human respiratory syncytial virus. J Gen Virol 66 (Pt 10): 2111-2124.
13. Anderson LJ, Hierholzer JC, Tsou C, Hendry RM, Fernie BF, et al. (1985) Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 151: 626-633.
14. Peret TC, Hall CB, Schnabel KC, Golub JA, Anderson LJ, (1998) Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community. J Gen Virol 79 (Pt 9): 2221-2229.
15. Hall CB, Walsh EE, Schnabel KC, Long CE, McConnochie KM, et al. (1990) Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis 162: 1283-1290.
16. Mufson MA, Belshe RB, Orvell C, Norrby E, (1988) Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986. J Infect Dis 157: 143-148.
17. Hendry RM, Pierik LT, McIntosh K, (1989) Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987. J Infect Dis 160: 185-190.
18. Johnson PR, Spriggs MK, Olmsted RA, Collins PL, (1987) The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci U S A 84: 5625-5629.
19. Sullender WM (2000) Respiratory syncytial virus genetic and antigenic diversity. Clin Microbiol Rev 13: 1-15, table of contents.
20. Chin J, Magoffin RL, Shearer LA, Schieble JH, Lennette EH, (1969) Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol 89: 449-463.
21. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE, (1969) An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 89: 405-421.
22. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, et al. (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89: 422-434.
23. Murphy BR, Walsh EE, (1988) Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. J Clin Microbiol 26: 1595-1597.
24. Olson MR, Varga SM, (2007) CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. J Immunol 179: 5415-5424.
25. Castilow EM, Olson MR, Meyerholz DK, Varga SM, (2008) Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus. J Virol 82: 2196-2207.
26. Kruijsen D, Schijf MA, Lukens MV, van Uden NO, Kimpen JL, et al. (2011) Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV. Vaccine 29: 2730-2741.
27. Kruijsen D, Bakkers MJ, van Uden NO, Viveen MC, van der Sluis TC, et al. (2010) Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections. J Immunol 185: 6489-6498.
28. Friedewald WT, Forsyth BR, Smith CB, Gharpure MA, Chanock RM, (1968) Low-temperature-grown RS virus in adult volunteers. JAMA 204: 690-694.
29. Kim HW, Arrobio JO, Pyles G, Brandt CD, Camargo E, et al. (1971) Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics 48: 745-755.
30. Wright PF, Mills J, Chanock RM, (1971) Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults. J Infect Dis 124: 505-511.
31. Murphy BR, Hall SL, Kulkarni AB, Crowe JE Jr, Collins PL, et al. (1994) An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res 32: 13-36.
32. Tang YW, Graham BS, (1997) T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J Clin Invest 99: 2183-2191.
33. Klein Klouwenberg P, Tan L, Werkman W, van Bleek GM, Coenjaerts F, (2009) The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus. Crit Rev Immunol 29: 531-550.
34. Grenfell BT, Pybus OG, Gog JR, Wood JL, Daly JM, et al. (2004) Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303: 327-332.
35. Kumaria R, Iyer LR, Hibberd ML, Simoes EA, Sugrue RJ, (2011) Whole genome characterization of non-tissue culture adapted HRSV strains in severely infected children. Virol J 8: 372.
36. Rebuffo-Scheer C, Bose M, He J, Khaja S, Ulatowski M, et al. (2011) Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. PLoS One 6: e25468.
37. Holmes EC, Grenfell BT, (2009) Discovering the phylodynamics of RNA viruses. PLoS Comput Biol 5: e1000505.
38. Gupta R, Brunak S (2002) Prediction of glycosylation across the human proteome and the correlation to protein function. Pac Symp Biocomput: 310-322.
39. Katoh K, Misawa K, Kuma K, Miyata T, (2002) MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res 30: 3059-3066.
40. Martin DP, Lemey P, Lott M, Moulton V, Posada D, et al. (2010) RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics 26: 2462-2463.
41. Martin DP, Lemey P, Posada D, (2011) Analysing recombination in nucleotide sequences. Mol Ecol Resour 11: 943-955.
42. Drummond A, Pybus OG, Rambaut A, (2003) Inference of viral evolutionary rates from molecular sequences. Adv Parasitol 54: 331-358.
43. Guindon S, Delsuc F, Dufayard JF, Gascuel O, (2009) Estimating maximum likelihood phylogenies with PhyML. Methods Mol Biol 537: 113-137.
44. Drummond AJ, Suchard MA, Xie D, Rambaut A (2012) Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol.
45. Drummond AJ, Ho SY, Phillips MJ, Rambaut A, (2006) Relaxed phylogenetics and dating with confidence. PLoS Biol 4: e88.
46. Xie W, Lewis PO, Fan Y, Kuo L, Chen MH, (2011) Improving marginal likelihood estimation for Bayesian phylogenetic model selection. Syst Biol 60: 150-160.
47. Baele G, Lemey P, Bedford T, Rambaut A, Suchard MA, et al. (2012) Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty. Mol Biol Evol.
48. Shapiro B, Ho SY, Drummond AJ, Suchard MA, Pybus OG, et al. (2011) A Bayesian phylogenetic method to estimate unknown sequence ages. Mol Biol Evol 28: 879-887.
49. Ho SY, Phillips MJ, Cooper A, Drummond AJ, (2005) Time dependency of molecular rate estimates and systematic overestimation of recent divergence times. Mol Biol Evol 22: 1561-1568.
50. Drummond AJ, Suchard MA, (2008) Fully Bayesian tests of neutrality using genealogical summary statistics. BMC Genet 9: 68.
51. Siebenga JJ, Lemey P, Kosakovsky Pond SL, Rambaut A, Vennema H, et al. (2010) Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog 6: e1000884.
52. Kosakovsky Pond SL, Frost SD, (2005) Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol 22: 1208-1222.
53. Lemey P, Minin VN, Bielejec F, Kosakovsky Pond SL, Suchard MA (2012) A counting renaissance: Combining stochastic mapping and empirical Bayes to quickly detect amino acid sites under positive selection. Bioinformatics.
54. Pond SK, Muse SV, (2005) Site-to-site variation of synonymous substitution rates. Mol Biol Evol 22: 2375-2385.
55. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K, et al. (2012) Detecting individual sites subject to episodic diversifying selection. PLoS Genet 8: e1002764.
56. Wertheim JO, Worobey M, (2009) Relaxed selection and the evolution of RNA virus mucin-like pathogenicity factors. J Virol 83: 4690-4694.
57. Simard C, Nadon F, Seguin C, Trudel M, (1995) Evidence that the amino acid region 124-203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection. Antiviral Res 28: 303-315.
58. Langedijk JP, de Groot BL, Berendsen HJ, van Oirschot JT, (1998) Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor. Virology 243: 293-302.
59. Plotnicky-Gilquin H, Goetsch L, Huss T, Champion T, Beck A, et al. (1999) Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein. J Virol 73: 5637-5645.
60. Martin D, Calder LJ, Garcia-Barreno B, Skehel JJ, Melero JA, (2006) Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity. J Gen Virol 87: 1649-1658.
61. McLellan JS, Yang Y, Graham BS, Kwong PD, (2011) Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J Virol 85: 7788-7796.
62. Zimmer G, Trotz I, Herrler G, (2001) N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus. J Virol 75: 4744-4751.
63. Lefeuvre P, Lett JM, Varsani A, Martin DP, (2009) Widely conserved recombination patterns among single-stranded DNA viruses. J Virol 83: 2697-2707.
64. Zlateva KT, Lemey P, Vandamme AM, Van Ranst M, (2004) Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein. J Virol 78: 4675-4683.
65. Lemey P, Kosakovsky Pond SL, Drummond AJ, Pybus OG, Shapiro B, et al. (2007) Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol 3: e29.
66. Zlateva KT, Lemey P, Moes E, Vandamme AM, Van Ranst M, (2005) Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein. J Virol 79: 9157-9167.
67. Woelk CH, Holmes EC, (2001) Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). J Mol Evol 52: 182-192.
68. Spann KM, Collins PL, Teng MN, (2003) Genetic recombination during coinfection of two mutants of human respiratory syncytial virus. J Virol 77: 11201-11211.
69. Rixon HW, Brown C, Brown G, Sugrue RJ, (2002) Multiple glycosylated forms of the respiratory syncytial virus fusion protein are expressed in virus-infected cells. J Gen Virol 83: 61-66.
70. Rueda P, Delgado T, Portela A, Melero JA, Garcia-Barreno B, (1991) Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies. J Virol 65: 3374-3378.
71. Botosso VF, Zanotto PM, Ueda M, Arruda E, Gilio AE, et al. (2009) Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus. PLoS Pathog 5: e1000254.
72. Gaunt ER, Jansen RR, Poovorawan Y, Templeton KE, Toms GL, et al. (2011) Molecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus. PLoS One 6: e17427.